Abstract
Human serum paraoxonase 1 (PON1) is known as an antioxidant and is also involved in the detoxification of many compounds. In this study, a novel purification strategy was employed to purify the PON1 by using cholesterol-conjugated magnetic nanoparticles. Magnetic nanoparticles were synthesized and conjugated with cholesterol through diazotized p-aminohippuric acid. In Fourier transform infrared spectrum of cholesterol-p-aminohippuric acid-Fe3O4 nanoparticles, the appearance of peaks at 3,358.3, 1,645 cm−1, and at 2,334.9 cm−1 confirmed the conjugation. The molecular weight of purified PON1 was nearly 45 kDa on sodium dodecyl sulfate (SDS)–polyacrylamide gel electrophoresis (PAGE), and isoelectric point was 5.3. The specific activity was 438 U mg−1 protein, and the purification fold was 515 with 73% yield. The K m values were 1.3 and 0.74 mM with paraoxon and phenyl acetate, respectively. Western blot of 2D-PAGE confirmed the homogeneity and stability of the enzyme. Mg+2, Mn+2, glycerol, (NH4)2SO4, PEG 6000, Triton X-100, and phenylmethylsulfonyl fluoride did not show any effect on activity. Pb+2, Co+2, Zn2+, ethanol, β-mercaptoethanol, and acetone reduced the activity while Ni2+, Cd2+, Cu2+, iodoacetic acid, SDS, dimethylformamide, DMSO inhibited the activity. In vitro enzyme activity was slightly reduced by acetyl salicylic and acetaminophen and reduced 50% with amino glycosides and ampicillin antibiotics at concentrations of 0.6 and 30 mg ml−1, respectively. This is the first report for the synthesis of cholesterol-conjugated magnetic nanoparticles for simple purification of PON1 enzyme.
Similar content being viewed by others
References
Mackness, M. I., Arrol, S., Mackness, B., & Durrington, P. N. (1997). Lancet, 349, 851–852.
Mochizuki, H., Scherer, S. T., Nickle, D. J., Majer, M., Huizenga, J. J., Tsui, L. C., et al. (1998). Gene, 213, 149–157.
Davies, H. G., Richter, R., Keifer, J. M., Broomfield, C. A., Sowalla, J., & Furlong, C. E. (1996). Nature Genetics, 14, 334–336.
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., et al. (2000). Drug Metabolism & Disposition, 28(11), 1335–1342.
Durringhton, P. N., Mackness, B., & Mackness, M. J. (2001). Arteriosclerosis Thrombosis Vascular Biology, 21, 473–480.
Sorgob, M. A., & Vilanova, E. (2002). Toxicology Letter, 128, 215–228.
Cherry, N., Mackness, M., Durrington, P., Povey, A., Dippnall, M., Smith, T., et al. (2002). Lancet, 359, 763–764.
Mackness, B. P., Durrington, A., Povey, S., Thomson, M., Dippnall, M., Mackness, T., et al. (2003). Pharmacogenetics, 13, 81–88.
La Du, B. N. (1992). Pharmacogenetics of drug metabolism. New York: Pergamon Press.
Sorenson, R. C., Primo-Parma, S. I., Teiber, J., & La Du, B. N. (1996). Genomics, 33, 498–509.
Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000). Journal of Biological Chemistry, 43, 33435–33442.
Aviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., et al. (1998). Arteriosclerosis Thrombosis Vascular Biology, 10, 1617–1624.
Sinan, S., Kockar, F., Gencer, N., Yildirim, H., & Arslan, O. (2006). Biochemistry, 71, 46–50.
Costa, L. G., Cole, T. B., Jarvik, G. P., & Furlong, C. E. (2003). Annual Review of Medicine, 54, 371–392.
Tischer, W., & Wedekind, F. (1999). Topics in Current Chemistry, 200, 95–125.
Jia, H., Guangyu, Z., & Wang, P. (2003). Biotechnology Bioengineering, 84, 407–413.
Bornscheuer, U. T. (2003). Angewandte Chemie International, 42, 3336–3337.
Schutt, W., Gruttner, C., Hafeli, U., Zborowski, M., Teller, J., Putzar, H., et al. (1997). Hybridoma, 16, 109–117.
Rudge, S. R., Kurtz, T. L., Vessely, C. R., Catterall, L. G., & Williamson, D. L. (2000). Biomaterials, 21, 1411–1420.
Josephson, L., Perez, J. M., & Weissleder, R. (2001). Angewandte Chemie International, 40, 3204–3206.
Katz, E., Sheeney-Haj-Ichia, L., Buckmann, A. F., & Willner, I. (2002). Angewandte Chemie International, 41, 1343–1346.
Gan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991). Drug Metabolism & Disposition, 19, 100–106.
Gupta, P. K., & Hung, C. T. (1989). Life Sciences, 44, 175–186.
Sahoo, K. S., & Labhasetwar, V. (2003). Drug Discovery Today, 8, 1112–1120.
Huang, S. H., Liao, M. H., & Chen, D. H. (2003). Biotechnology Progress, 19, 1095–1100.
Takeshi, K., Tomoichiro, O., Mitsuaki, I., Tohru, E., Takayuki, F., Eiji, S., et al. (2000). Journal of Lipid Research, 41, 1358–1363.
Golmanesh, L., Mehrani, H., & Tabei, M. (2008). Journal of Biochemistry Biophysics Methods, 70, 1037–1042.
Furlong, C. E., Costa, L. G., Hasett, C., Richter, R. J., Sundstorm, J. A., Alder, D. A., et al. (1993). Chemical Biology Interaction, 87, 35–48.
Durrington, P. N., Mackness, B., & Mackness, M. I. (2002). Arteriosclerosis Thrombosis Vascular Biology, 22, 1248–1250.
Samra, Z. Q., & Athar, M. A. (2009). Biotechnology Bioprocess Engineering (in press).
Liao, M. H., & Chen, D. H. (2002). Journal of Materials Chemistry, 12, 3654–3659.
Weiler, E. W. (1980). Planta, 148, 262–272.
Moesta, P., Hahn, M. G., & Grisebach, H. (1983). Planta Physiology, 73, 233–237.
Bradford, M. M. (1976). Analytical Biochemistry, 72, 248–251.
Laemmli, U. K. (1970). Nature, 227, 680–685.
Towbin, H. K., Staehelin, T., & Gordon, J. (1979). Proceeding of National Academy of Science, 76, 4350–4359.
Harlow, E. D., & Lane, D. (1988). Antibodies, a laboratory manual. USA: CSH.
Walker, J. (1994). Methods in molecular biology: Basic protein and peptide protocol (Vol. 32). Totowa: Humana.
Tougou, K., Nakamura, S., & Wantanabe, S. (1998). Drug Metabolism & Disposition, 26, 355–359.
Malin, R., Laaksonen, R., & Knuuti, J. (2001). Pharmacogenetics, 11, 625–633.
Tomas, M., Senti, M., Gracia-Faria, F., Vila, J., Torrents, A., Covas, M., et al. (2000). Arteriosclerosis Thrombosis Vascular Biology, 20, 2113–2119.
Leviev, I., & James, R. (2000). Atherosclerosis, 151, 41–48.
Kudchodkar, B. J., Lacko, A. G., Dory, L., & Fungwe, T. V. (2000). Journal of Nutrition, 30, 2427–2433.
Shih, D. M., Gu, L., Xia, Y. R., Navab, M., Li, W. F., Hama, S., et al. (1998). Nature, 394, 284–287.
Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C. L., et al. (1999). Free Radical Biology & Medicine, 26(7–8), 892–904.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s12010-016-2268-4.
Rights and permissions
About this article
Cite this article
Samra, Z.Q., Shabir, S., Rehmat, Z. et al. Synthesis of Cholesterol-Conjugated Magnetic Nanoparticles for Purification of Human Paraoxonase 1. Appl Biochem Biotechnol 162, 671–686 (2010). https://doi.org/10.1007/s12010-009-8840-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-009-8840-4